• Profile
Close

Serum osteoprotegerin in prevalent hemodialysis patients: Associations with mortality, atherosclerosis and cardiac function

BMC Nephrology Sep 13, 2017

Collado S, et al. - Whether or not serum osteoprotegerin (OPG) and/or fetuin-A predicted mortality and cardiovascular (CV) morbidity and mortality in hemodialysis patients, was gauged in this study. In prevalent hemodialysis patients, OPG had an independent association with overall mortality, as well as clinical and subclinical atherosclerosis and cardiac function. However, this relationship was not seen for fetuin-A levels.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay